Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Study on Early Inflammatory, Cell Adhesion and Hemostatic Plasmatic Markers of Endothelial Dysfunction in Children With Sickle Cell Disease (SCD)

NCT04839159 is registered in ClinicalTrials.gov with Queen Fabiola Children's University Hospital as lead sponsor.

NCT NCT04839159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04839159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Study on Early Inflammatory, Cell Adhesion and Hemostatic Plasmatic Markers of Endothelial Dysfunction in Children With Sickle Cell Disease (SCD)
Lead sponsor
Queen Fabiola Children's University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 10, 2012
Completion date
June 30, 2021
Enrollment
41 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease